Company news

Scinopharm Taiwan, Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

ScinoPharm Secures U.S. FDA Approval for Glatiramer Acetate Injection for the Treatment of Multiple Sclerosis

January 5, 2026

Board of Directors approved the company's consolidated financial report of Q2, 2022

August 5, 2022

ScinoPharm Taiwan To Announce the ex-dividend record date and cash dividend distribution date approved by the Board of Directors

May 30, 2022

ScinoPharm Taiwan Announce the Company's 2022 Shareholders' Meeting approved to release the Directors and their representatives from non-competition restrictions

May 30, 2022

President & CEO Dr. Jo Shen to Retire, Dr. Yung-Fa (Fred) Chen to Succeed

July 11, 2014

Decks

The 5 newest of 45 decks. Every deck is listed under its year.